XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Statement of Cash Flows
11 Months Ended
Dec. 31, 2021
USD ($)
Cash Flows From Operating Activities:  
Net income $ 11,639,507
Adjustments to reconcile net loss to net cash used in operating activities:  
Investment income earned on investment held in Trust Account (16,116)
Change in fair value of derivative liabilities (17,270,000)
Transaction costs allocable to warrant liability 926,044
Excess fair value of private warrants over proceeds 4,080,000
Changes in operating assets and liabilities:  
Prepaid expenses (458,133)
Other assets (370,931)
Accounts payable and accrued expenses 341,555
Net Cash Used In Operating Activities (1,128,074)
Cash Flows From Investing Activities:  
Cash deposited into Trust Account (234,600,000)
Net Cash Used In Investing Activities (234,600,000)
Cash Flows From Financing Activities:  
Proceeds from sale of Units in Public Offering, net of underwriting fee 225,400,000
Proceeds from sale of Private Placement Warrants 12,000,000
Proceeds from note payable 250,000
Repayment of note payable (250,000)
Proceeds from issuance of Class B common stock to sponsor 25,000
Proceeds from related party payable 20,000
Repayment of related party payable (32,111)
Payment of offering costs (705,589)
Net Cash Provided By Financing Activities 236,707,300
Net change in cash 979,226
Cash at beginning of period 0
Cash at end of period 979,226
Supplemental disclosure of non-cash financing activities:  
Deferred underwriters' commissions 8,050,000
Offering costs included in accrued offering costs 17,388
Expenses paid by related parties on behalf of the Company 15,984
Initial classification of fair value of Public warrants 15,180,000
Initial classification value of common stock subject to possible redemption 202,355,564
Remeasurement of Class A common stock subject to possible redemption $ 32,244,436